These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3246216)

  • 1. Pathological brain ageing: evaluation of the efficacy of a pharmacological aid.
    Guarnaschelli C; Fugazza G; Pistarini C
    Drugs Exp Clin Res; 1988; 14(11):715-8. PubMed ID: 3246216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R
    Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-acetylcarnitine treatment of mental decline in the elderly.
    Salvioli G; Neri M
    Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical development of a drug for brain aging. Current limitations and future prospects].
    Zerbini O; Recchia G; Fabbri L
    Clin Ter; 1990 Mar; 132(6 Suppl):451-5. PubMed ID: 2140969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders.
    Bella R; Biondi R; Raffaele R; Pennisi G
    Int J Clin Pharmacol Res; 1990; 10(6):355-60. PubMed ID: 2099360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
    Sinforiani E; Iannuccelli M; Mauri M; Costa A; Merlo P; Bono G; Nappi G
    Int J Clin Pharmacol Res; 1990; 10(1-2):69-74. PubMed ID: 2387665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
    Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
    Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methodology of a clinical controlled study of L-acetylcarnitine].
    Neri M; Cortelloni C; De Vreese L
    Clin Ter; 1990 Mar; 132(6 Suppl):457-68. PubMed ID: 2140970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo.
    Tempesta E; Casella L; Pirrongelli C; Janiri L; Calvani M; Ancona L
    Drugs Exp Clin Res; 1987; 13(7):417-23. PubMed ID: 3308388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
    Bonavita E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.
    Lovett WC; Stokes DK; Taylor LB; Young ML; Free SM; Phelan DG
    J Clin Psychiatry; 1987 Jun; 48(6):234-6. PubMed ID: 3294815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The evaluation of subjective quality of life in patients with schizophrenia or depression].
    Jarema M; Konieczyńska Z; Główczak M; Szaniawska A; Meder J; Jakubiak A
    Psychiatr Pol; 1995; 29(5):641-53. PubMed ID: 8577905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The patient with dementia, the caregiver and the doctor: cognition, depression and quality of life from three perspectives.
    Arlt S; Hornung J; Eichenlaub M; Jahn H; Bullinger M; Petersen C
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):604-10. PubMed ID: 18008392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methodological premises of statistical analysis of the data].
    Bamfi F; Girelli M
    Clin Ter; 1990 Mar; 132(6 Suppl):475-8. PubMed ID: 2140972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A controlled clinical study on the efficacy of L-acetylcarnitine in the treatment of mild-to-moderate mental deterioration in the aged. Conclusions].
    Genazzani E
    Clin Ter; 1990 Mar; 132(6 Suppl):511-2. PubMed ID: 2140974
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term treatment of patients in neurological practices with antidepressive agents].
    Schüssler G; Linden M; Müller-Oerlinghausen B
    Nervenarzt; 1984 Mar; 55(3):137-42. PubMed ID: 6425705
    [No Abstract]   [Full Text] [Related]  

  • 17. Buspirone's efficacy in organic-induced aggression.
    Stanislav SW; Fabre T; Crismon ML; Childs A
    J Clin Psychopharmacol; 1994 Apr; 14(2):126-30. PubMed ID: 8195453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
    Cavallini G; Modenini F; Vitali G; Koverech A
    Urology; 2005 Nov; 66(5):1080-5. PubMed ID: 16286128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate in the treatment of temper outbursts.
    Giakas WJ; Seibyl JP; Mazure CM
    J Clin Psychiatry; 1990 Dec; 51(12):525. PubMed ID: 2258370
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the efficacy of L-acetylcarnitine and tiapride combination in elderly patients with behavioral disorders].
    De Marco F; Ascione C; Di Pietro E; Ulisse T; D'Ambra L; Carbone M
    Minerva Psichiatr; 1991; 32(2):103-7. PubMed ID: 1870410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.